Wesley J R
Division of Pediatric Surgery, Mayo Clinic, Rochester, MN 55905.
Semin Pediatr Surg. 1992 Aug;1(3):188-201.
The development of permanent central venous access devices in the last 20 years has been accompanied by decreased complication rates, improved patient comfort, and increased cost-effectiveness. Subclavian venous access, first applied to infants and small children in the early 1970s, has given way to the Silastic permanent right atrial catheter by both cutdown and percutaneous techniques. The disadvantages of an occlusive aseptic dressing, frequent catheter irrigation, and disturbance of body image led to development of the totally implantable venous access system, which has been successfully used for long-term infusion of chemotherapeutic agents, antibiotics, blood products, and total parenteral nutrition. The recent introduction of permanent peripheral central venous catheters has further decreased the expense and complication rate of long-term venous access in infants and children. These developments and the accumulated expertise in finding alternative venous access sites (common facial, deep inferior epigastric, lumbar, and azygos veins) have helped minimize mechanical and septic complications and have increased the safety of even the most difficult venous access procedures.
在过去20年中,永久性中心静脉通路装置的发展伴随着并发症发生率的降低、患者舒适度的提高以及成本效益的增加。20世纪70年代初首次应用于婴幼儿的锁骨下静脉通路,无论是通过切开法还是经皮技术,都已被硅橡胶永久性右心房导管所取代。封闭无菌敷料、频繁导管冲洗以及对身体形象的干扰等缺点促使了完全植入式静脉通路系统的发展,该系统已成功用于长期输注化疗药物、抗生素、血液制品和全胃肠外营养。永久性外周中心静脉导管的近期引入进一步降低了婴幼儿长期静脉通路的费用和并发症发生率。这些进展以及在寻找替代静脉通路部位(面总静脉、腹壁下深静脉、腰静脉和奇静脉)方面积累的专业知识,有助于将机械性和感染性并发症降至最低,并提高了即使是最困难的静脉通路操作的安全性。